In the latest session, Redhill Biopharma Ltd. ADR (NASDAQ: RDHL) closed at $0.45 down -5.69% from its previous closing price of $0.48. In other words, the price has decreased by -$0.0274 from its previous closing price. On the day, 532749 shares were traded.
Ratios:
For a deeper understanding of Redhill Biopharma Ltd. ADR’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.78 and its Current Ratio is at 0.96. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on August 31, 2021, initiated with a Overweight rating and assigned the stock a target price of $22.
On May 18, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $23.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RDHL now has a Market Capitalization of 14.47M and an Enterprise Value of 9.74M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.38 while its Price-to-Book (P/B) ratio in mrq is 0.52. Its current Enterprise Value per Revenue stands at 0.27 whereas that against EBITDA is 0.18.
Stock Price History:
Over the past 52 weeks, RDHL has reached a high of $3.60, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is 0.5373, while the 200-Day Moving Average is calculated to be 0.8524.
Shares Statistics:
For the past three months, RDHL has traded an average of 1.24M shares per day and 344.79k over the past ten days. A total of 29.70M shares are outstanding, with a floating share count of 29.55M. Insiders hold about 0.50% of the company’s shares, while institutions hold 6.70% stake in the company. Shares short for RDHL as of Mar 15, 2024 were 1.06M with a Short Ratio of 0.73, compared to 615.65k on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.56% and a Short% of Float of 3.56%.
Earnings Estimates
There are 0 different market analysts currently analyzing its stock. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
Revenue Estimates
Based on 1 analysts’ estimates, the company’s revenue will be $38M in the next fiscal year. The high estimate is $38M and the low estimate is $38M. The average revenue growth estimate for next year is up 82.70% from the average revenue estimate for this year.
